Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease

Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease

US Patent 5837852 · Granted Nov 17, 1998

Estimated economic value: $175,052,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2022
Polypeptides targeting HIV fusion2021
Compounds and methods for activating the apoptotic arm of the unfolded protein r2020
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2020
Polypeptides targeting HIV fusion2019
Compounds and methods for activating the apoptotic arm of the unfolded protein r2017
Piperazine analogs as broad-spectrum influenza antivirals2013
N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro2009
Recombinant negative strand RNA virus expression systems and vaccines2007
Iminothiazolidinones as inhibitors of HCV replication2007
Bicyclic heterocycles as HIV integrase inhibitors2007
Bicyclic heterocycles as HIV integrase inhibitors2007